Lazard Capital Downgrades Acorda Therapeutics (ACOR) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

January 30, 2012 8:20 AM EST
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%

Rating Summary:
    4 Buy, 12 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Lazard Capital downgraded Acorda Therapeutics (NASDAQ: ACOR) from Buy to Neutral.

For an analyst ratings summary and ratings history on Acorda Therapeutics click here. For more ratings news on Acorda Therapeutics click here.

Shares of Acorda Therapeutics closed at $26.29 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Lazard